ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1831

A Novel Graph Theoretic Approach Applied to Modular Repertoire Analysis Identifies a Dual Molecular Progression in Adult SLE Patients, with Distinct Interferon and Neutrophil Transcription Patterns

Ilya Korsunski1, Noémie Jourde-Chiche2,3, Peter K. Gregersen1, Damien Chaussabel4, Laurent Chiche5 and Naomi I Maria6, 1Center for Genomics and Human Genetics, Feinstein Institute for Medical Research, Manhasset, NY, 2Vascular Research Center of Marseille, Aix-Marseille Univ., Vascular Research Center of Marseille, Marseille, France, 3Nephrology, AP-HM, Department of Nephrology, CHU Conception, Marseille, France, 4Translational Medicine, Sidra Medical and Research Center, Doha, Qatar, 5internal medicine, Hopital Europeen, Marseille, France, 6Center for Autoimmune and Musculoskeletal Diseases, Feinstein Institute for Medical Research, Manhasset, NY

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Disease Activity, Disease Sub-phenotyping, interferons, neutrophils and systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 14, 2016

Title: Systemic Lupus Erythematosus – Human Etiology and Pathogenesis - Poster I

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:  Gene expression studies support a pivotal role for type I interferon (IFN) in SLE. Previous work using a modular repertoire analysis based on co-clustered gene sets, has demonstrated that the SLE IFN signature is not restricted to a type I IFN signature, but involves the gradual activation of 3 distinct IFN modules (M1.2, M3.4 and M5.12) driven by various IFN types. The aim of this study was to refine and discover novel modular interactions in adult SLE patients.

Methods: Consecutive SLE patients fulfilling the ACR criteria were enrolled (n=157 samples). Disease activity (DA) was measured according to the SELENA-SLEDAI score. Microarray data were generated using Illumina beadchips. Modular repertoire analyses were performed using the second generation of a blood modular framework comprising 260 modules. Modules with 20% transcripts differentially expressed compared to healthy matched controls were considered active. A novel graph theoretic approach, previously applied to the analysis of somatic evolution in cancer (unpublished), was used to generate an ordered, branching progression model of modular activation in which upstream module activity predisposes the activation of downstream modules. An SLE-specific graph based on module activation in our dataset was built in order to generate hypotheses regarding disease progression in SLE. Trajectories of a focused subgraph were enumerated and samples were clustered to their most likely trajectory group. Significance to clinical characteristics was evaluated using Fisher’s exact test and ANOVA, for categorical and continuous characteristics, respectively.

Results:  The graph theoretic analysis revealed two distinct patterns involving IFN and neutrophil related modules. Both patterns involved the upregulation of M1.2 followed by M3.4. At this point, the patterns split into the activation of either M5.12 or the M5.15 neutrophil module. Along the shared trajectory, we observed a monotonic increase in DA, dsDNA titers, and corticosteroid dosage. The subjects on the neutrophil (M5.15) trajectory had a marked increase in DA and corticosteroid dosage, although dsDNA levels were unchanged. Moreover, the neutrophil trajectory also had a larger (p=0.04) enrichment for renal involvement (80%) than the M5.12 IFN trajectory (40%). 

Conclusion:  Our analysis revealed a refinement within the hierarchical structure of the peripheral blood IFN modules previously described. Two subgroups, defined by progression along disjoint paths bolstered by their association to overall DA, active nephritis, dsDNA levels, and corticosteroid dosage, are identified. This suggests a dual mode of disease progression in SLE, with either the completion of IFN signature (to include IFNγ) or the activation of neutrophil path associated with renal involvement. ACR2016_Graph theory figure


Disclosure: I. Korsunski, None; N. Jourde-Chiche, None; P. K. Gregersen, None; D. Chaussabel, None; L. Chiche, None; N. I. Maria, None.

To cite this abstract in AMA style:

Korsunski I, Jourde-Chiche N, Gregersen PK, Chaussabel D, Chiche L, Maria NI. A Novel Graph Theoretic Approach Applied to Modular Repertoire Analysis Identifies a Dual Molecular Progression in Adult SLE Patients, with Distinct Interferon and Neutrophil Transcription Patterns [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/a-novel-graph-theoretic-approach-applied-to-modular-repertoire-analysis-identifies-a-dual-molecular-progression-in-adult-sle-patients-with-distinct-interferon-and-neutrophil-transcription-patterns/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/a-novel-graph-theoretic-approach-applied-to-modular-repertoire-analysis-identifies-a-dual-molecular-progression-in-adult-sle-patients-with-distinct-interferon-and-neutrophil-transcription-patterns/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology